An Index of the Value in Large Cap PharmaCos’ Mid- to Early-Stage Pipelines
Summary and Investment Conclusion Capital markets can see the characteristics of, and thus place reasonable values on, drug products that are on-market, in registration, or in very late (phase III)...
View ArticleSSR Index of Drug and Biotech Pipeline Values
Background Product pipelines account for a large percentage of drug and biotech companies’ total values, however relatively little information about pipeline products is available through traditional...
View Article
More Pages to Explore .....
